Work

O-187 Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in Non-Small Cell Lung Cancer (NSCLC) patients after prior chemotherapy

Year: 2005

Type: conference-abstract

Source: Lung Cancer

DOI: 10.1016/s0169-5002(05)80321-6

Authors: R. Herbst, A. Davies, B. Johnson, R. Natale, T. Dang, J. Murren, J. Schiller, L. Garland, V. Miller, D. Mendelson, Y. Melenevsky, D. Devries, A. Van Den Abbeele, D. Eberhard, B. Lyons, S. Lutzker

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2087694403

Cites:

Cited by: 5

Related to: 10